Advanced search
Publication Cover
Journal of Drug Targeting Volume 24, 2016 - Issue 9: Special issue in honour of Professor Pieter R Cullis Lifetime Achievement Award winner 2016
Submit an article Journal homepage
176
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Specific delivery of an immunosuppressive drug to splenic B cells by antigen-modified liposomes and its antiallergic effect

Kosuke ShimizuDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
,
Haruna MiyauchiDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
,
Takeo UrakamiDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
,
Kanae Yamamura-IchikawaDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
,
Sei YonezawaDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
,
Tomohiro AsaiDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, Japan
&
Naoto OkuDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Suruga-Ku, Shizuoka, JapanCorrespondence[email protected]
 show all
Pages 890-895 | Received 16 Feb 2016, Accepted 27 Mar 2016, Published online: 25 May 2016

References

  • Devillier P , Dreyfus JF , Demoly P , Calderon MA. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med 2014;12:71.
  • Rosner-Friese K , Kaul S , Vieths S , Pfaar O. Environmental exposure chambers in allergen immunotherapy trials: current status and clinical validation needs. J Allergy Clin Immunol 2015;135:636–43.
  • Allen TM , Cullis PR. Drug delivery systems: entering the mainstream. Science 2004;303:1818–22.
  • Allen TM , Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013;65:36–48.
  • Ikemoto K , Shimizu K , Ohashi K , et al . Bauhinia purprea agglutinin-modified liposomes for human prostate cancer treatment. Cancer Sci 2016;107:53–9.
  • Oku N , Yamashita M , Katayama Y , et al . PET imaging of brain cancer with positron emitter-labeled liposomes. Int J Pharm 2011;403:170–7.
  • Ichikawa K , Urakami T , Yonezawa S , et al . Enhanced desensitization efficacy by liposomal conjugation of a specific antigen. Int J Pharm 2007;336:391–5.
  • Ichikawa K , Asai T , Shimizu K , et al . Suppression of immune response by antigen-modified liposomes encapsulating model agents: a novel strategy for the treatment of allergy. J Control Release 2013;167:284–9.
  • Fukuta T , Ishii T , Asai T , et al . Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. Eur J Pharm Biopharm 2015;97:1–7.
  • Farkas SA , Schnitzbauer AA , Kirchner G , et al . Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009;22:49–60.
  • Naesens M , Kuypers DR , Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009;4:481–508.
  • Patel P , Patel H , Panchal S , Mehta T. Formulation strategies for drug delivery of tacrolimus: an overview. Int J Pharm Investig 2012;2:169–75.
  • Ishii T , Asai T , Oyama D , et al . Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506. FASEB J 2013;27:1362–70.
  • Dos Santos N , Allen C , Doppen AM , et al . Influence of poly (ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta 2007;1768:1367–77.
  • Cinamon G , Zachariah MA , Lam OM , et al . Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008;9:54–62.
  • Shimizu T , Mima Y , Hashimoto Y , et al . Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells. Immunobiology 2015;220:1151–60.
  • Yu Z , Zhou X , Yu S , et al . IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. Mol Med Rep 2015;11:37–42.
  • Bhashyam AR , Mogayzel PJ Jr , McGrath-Morrow S , et al . A pilot study to examine the effect of chronic treatment with immunosuppressive drugs on mucociliary clearance in a vagotomized murine model. PLoS One 2012;7:e45312.
  • Araki K , Gangappa S , Dillehay DL , et al . Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J Exp Med 2010;207:2355–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.